Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genkinakaigo CoTSE:599A ROE % is 7.91% as of Dec. 2025, which is 42% below its 10-year median of 13.71. The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Genkinakaigo Co ranks worse than 55.56% on this metric.
The historical rank and industry rank for Genkinakaigo Co's ROE % or its related term are showing as below:
TSE:599A'
s ROE % Range Over the Past 10 Years
Min: 3.96 Med: 13.71 Max: 20.59
Current: 3.96
During the past 2 years, Genkinakaigo Co's highest ROE % was 20.59%. The lowest was 3.96%. And the median was 13.71%.
TSE:599A's ROE % is ranked worse than 55.56% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs TSE:599A: 3.96
Genkinakaigo Co (TSE:599A) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Genkinakaigo Co ROE % Related Terms
Genkinakaigo Co ROE % Historical Data
* Premium members only.
The historical data trend for Genkinakaigo Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genkinakaigo Co ROE % Chart
Genkinakaigo Co Annual Data
Trend
Jun24
Jun25
ROE %
20.59
6.83
Genkinakaigo Co Semi-Annual Data
Jun24
Jun25
Dec25
ROE %
0.00
0.00
7.91
TSE:599A vs HCA, THC, DVA: ROE % Comparison
For the Medical Care Facilities subindustry, Genkinakaigo Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genkinakaigo Co ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genkinakaigo Co's ROE % distribution charts can be found below:
* The bar in red indicates where Genkinakaigo Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Genkinakaigo Co (TSE:599A) has a ROE % of 7.91% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Genkinakaigo Co and its competitors. This is 42% below median its historical median of 13.71. Over the past decade, Genkinakaigo Co's ROE % has ranged from 3.96 to 20.59. According to the industry distribution chart, Genkinakaigo Co ranks #345 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 55.6%.
Is Genkinakaigo Co's ROE % too high?
Genkinakaigo Co's current ROE % of 7.91% is 42% below median its 10-year median of 13.71. Over the past 10 years, this metric has ranged from a low of 3.96 to a high of 20.59. The Healthcare Providers & Services industry median ROE % is 5.88. Genkinakaigo Co's value of 7.91% is 34.5% above this industry median. Based on the distribution chart, Genkinakaigo Co ranks #345 out of 621 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Genkinakaigo Co's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Genkinakaigo Co ranks #345 out of 621 companies for ROE %. This places Genkinakaigo Co in the lower half of its industry. The industry median ROE % is 5.88. Genkinakaigo Co's value of 7.91% is 34.5% above this benchmark. Historically, Genkinakaigo Co's own ROE % has ranged from 3.96 to 20.59 over the past decade. While the company's 10-year median is 13.71 vs. the industry median of 5.88, Genkinakaigo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genkinakaigo Co's current ROE % of 7.91% is 34.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Genkinakaigo Co and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genkinakaigo Co's current ROE % is 7.91%, which is 42% below median its own 10-year median of 13.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genkinakaigo Co stock overvalued right now?
Genkinakaigo Co (TSE:599A) has a current ROE % of 7.91%. The current ROE % is 7.91%, which is 42% below median its 10-year median of 13.71 and 34.5% above the Healthcare Providers & Services industry median of 5.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Genkinakaigo Co (TSE:599A), the current ROE % is 7.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:599A has been successfully added to your 
